Vanderbilt University Medical Center-Vanderbilt Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Vanderbilt University Medical Center-Vanderbilt Ingram Cancer Center has participated in 1 clinical trials.
Therapeutic areas: HRAS Gene Mutation, HNSCC.
Sponsors: Kura Oncology, Inc..
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt University Medical Center-Vanderbilt Ingram Cancer Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt University Medical Center-Vanderbilt Ingram Cancer Center has 1 clinical trials on record. Their work covers HRAS Gene Mutation, HNSCC.
Vanderbilt University Medical Center-Vanderbilt Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.